The Role and Clinical Relevance of Disseminated Tumor Cells in Breast Cancer

被引:19
作者
Banys, Malgorzata [1 ,2 ]
Krawczyk, Natalia [1 ]
Fehm, Tanja [1 ]
机构
[1] Univ Dusseldorf, Dept Obstet & Gynecol, D-40225 Dusseldorf, Germany
[2] Marien Hosp, Dept Obstet & Gynecol, D-22087 Hamburg, Germany
关键词
breast cancer; bone marrow; disseminated tumor cell; circulating tumor cell; tumor cell dissemination; CIRCULATING EPITHELIAL-CELLS; BONE-MARROW; PERIPHERAL-BLOOD; HER2; STATUS; MICROMETASTATIC CELLS; PROGNOSTIC RELEVANCE; RECEPTOR EXPRESSION; SYSTEMIC THERAPY; STAGE-I; RT-PCR;
D O I
10.3390/cancers6010143
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor cell dissemination is a common phenomenon observed in most cancers of epithelial origin. One-third of breast cancer patients present with disseminated tumor cells (DTCs) in bone marrow at time of diagnosis; these patients, as well as patients with persistent DTCs, have significantly worse clinical outcome than DTC-negative patients. Since DTC phenotype may differ from the primary tumor with regard to ER and HER2 status, reevaluation of predictive markers on DTCs may optimize treatment choices. In the present review, we report on the clinical relevance of DTC detection in breast cancer.
引用
收藏
页码:143 / 152
页数:10
相关论文
共 55 条
[1]  
Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
[2]   Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients [J].
Aktas, Bahriye ;
Mueller, Volkmar ;
Tewes, Mitra ;
Zeitz, Julia ;
Kasimir-Bauer, Sabine ;
Loehberg, Christian R. ;
Rack, Brigitte ;
Schneeweiss, Andreas ;
Fehm, Tanja .
GYNECOLOGIC ONCOLOGY, 2011, 122 (02) :356-360
[3]  
Ashworth T.R., 1869, Australas Med J, V14, P146
[4]   Dormancy in breast cancer [J].
Banys, Malgorzata ;
Hartkopf, Andreas D. ;
Krawczyk, Natalia ;
Kaiser, Tatjana ;
Meier-Stiegen, Franziska ;
Fehm, Tanja ;
Neubauer, Hans .
BREAST CANCER-TARGETS AND THERAPY, 2012, 4 :183-191
[5]   The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer [J].
Banys, Malgorzata ;
Krawczyk, Natalia ;
Becker, Sven ;
Jakubowska, Jolanta ;
Staebler, Annette ;
Wallwiener, Diethelm ;
Fehm, Tanja ;
Rothmund, Ralf .
BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (01) :121-129
[6]   Image analysis systems for the detection of disseminated breast cancer cells on bone-marrow cytospins [J].
Becker, S ;
Becker-Pergola, G ;
Fehm, T ;
Emig, R ;
Wallwiener, D ;
Solomayer, EF .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2005, 19 (03) :115-119
[7]   Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients [J].
Becker, Sven ;
Solomayer, Erich ;
Becker-Pergola, Graziella ;
Wallwiener, Diethelm ;
Fehm, Tanja .
BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 (02) :239-243
[8]   Evaluation of a RT-PCR based routine screening tool for the detection of disseminated epithelial cells in the bone marrow of breast cancer patients [J].
Becker, Sven ;
Becker-Pergola, Graziella ;
Banys, Malgorzata ;
Krawczyk, Natalia ;
Wallwiener, Diethelm ;
Solomayer, Erich ;
Schuetz, Christina ;
Fehm, Tanja .
BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (02) :227-233
[9]   Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer [J].
Bernhard, Helga ;
Neudorfer, Julia ;
Gebhard, Kerstin ;
Conrad, Heinke ;
Hermann, Christine ;
Naehrig, Joerg ;
Fend, Falko ;
Weber, Wolfgang ;
Busch, Dirk H. ;
Peschel, Christian .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (02) :271-280
[10]   Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials [J].
Bidard, Francois-Clement ;
Fehm, Tanja ;
Ignatiadis, Michail ;
Smerage, Jeffrey B. ;
Alix-Panabieres, Catherine ;
Janni, Wolfgang ;
Messina, Carlo ;
Paoletti, Costanza ;
Mueller, Volkmar ;
Hayes, Daniel F. ;
Piccart, Martine ;
Pierga, Jean-Yves .
CANCER AND METASTASIS REVIEWS, 2013, 32 (1-2) :179-188